HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Treatment of established peritoneal fibrosis by gene transfer of Smad7 in a rat model of peritoneal dialysis.

AbstractBACKGROUND/AIMS:
It has been shown that blockade of TGF-beta1 signaling with Smad7 prevents experimental peritoneal fibrosis. The present study investigated whether Smad7 has a therapeutic effect on established peritoneal fibrosis associated with peritoneal dialysis (PD).
METHODS:
A rat model of peritoneal fibrosis was induced by a daily intraperitoneal infusion of 4.25% Dianeal. After peritoneal fibrosis had been established on day 14, groups of 6 rats were treated intraperitoneally with gene transfer of Smad7 or control plasmids using an ultrasound-microbubble-mediated system for 2 weeks until day 28. In addition, a group of 6 diseased rats was euthanized on day 14 before treatment as the basal disease control.
RESULTS:
Compared to the control-treatment animals on day 28, real-time PCR, Western blot, and confocal microscopy revealed that Smad7 gene transfer significantly attenuated the increased peritoneal fibrosis including the thickening of fibrotic peritoneum, accumulation of alpha-SMA and collagen I, and an improvement in peritoneal dysfunction (all p < 0.05). Importantly, Smad7 treatment also improved the severity of peritoneal fibrosis and functional impairment when compared to those on day 14 before treatment (all p < 0.05). Inhibition of the established peritoneal fibrosis by Smad7 was associated with an abrogation of TGF-beta signaling and upregulation of TGF-beta1 and PAI-1.
CONCLUSIONS:
Smad7 gene therapy is able to inhibit established peritoneal fibrosis in a rat model of PD. Results from this study suggest that Smad7 may be a therapeutic agent for the treatment of peritoneal fibrosis associated with PD.
AuthorsYanyan Sun, Fengxin Zhu, Xueqing Yu, Jing Nie, Fengxian Huang, Xiaoyan Li, Ning Luo, Hui Yao Lan, Yongtao Wang
JournalAmerican journal of nephrology (Am J Nephrol) Vol. 30 Issue 1 Pg. 84-94 ( 2009) ISSN: 1421-9670 [Electronic] Switzerland
PMID19223683 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Smad7 Protein
  • Smad7 protein, rat
  • Transforming Growth Factor beta
Topics
  • Animals
  • Disease Models, Animal
  • Fibrosis (pathology, therapy)
  • Gene Transfer Techniques
  • Genetic Therapy (methods)
  • Microscopy, Confocal
  • Peritoneal Dialysis
  • Peritoneum
  • Rats
  • Reverse Transcriptase Polymerase Chain Reaction
  • Smad7 Protein (genetics, physiology)
  • Time Factors
  • Transforming Growth Factor beta (metabolism)
  • Transgenes
  • Ultrasonics

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: